Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fortress Biotech Inc.

http://www.fortressbiotech.com

Latest From Fortress Biotech Inc.

BridgeBio’s Hub-And-Spoke Model: An Interview With Cameron Turtle

Since raising $135m in 2017 to address rare, monogenic diseases, BridgeBio has launched or purchased 17 companies and built a pipeline of 30-plus candidates. Scrip checked in as the company nears commercialization.

Rare Diseases Business Strategies

Sentynl Signs Deal With Fortress’ Cyprium For ‘De-Risked’ Rare Disease Drug

Deal Snapshot: Sentynl will pay $20m in upfront and regulatory milestone payments through FDA approval, while Cyprium will retain 100% ownership of the priority review voucher.

Research & Development Deals

Scrip Asks…What Does 2021 Hold For Biopharma? Part 5: Business Environment And Strategy

A strong year is predicted for biopharma business with investment and deal making set to continue apace. Executives across industry share their forecasts for the year ahead.

Artificial Intelligence Brexit

Finance Watch: One Small Pain Drug Maker And Three Biotech SPACs Launch IPOs

After a brief lull in US initial public offerings, PainReform and three special purpose acquisition companies kicked off September’s IPOs. Also, Immunovant offering grossed $173.9m, Carlyle Group bought 5% stake in China’s Salubris and Erasca increased its series B to $236m. 

Financing Growth
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Aevitas Therapeutics, Inc.
    • Altamira Bio
    • Avenue Therapeutics, Inc. (ATXI)
    • Baergic Bio, Inc.
    • Caelum Biosciences Inc.
    • Cellvation, Inc.
    • Checkpoint Therapeutics, Inc.
    • Coronado Biosciences, Inc. (CNDO)
    • Cyprium Therapeutics, Inc.
    • DiaVax Biosciences
    • Helocyte, Inc.
    • Journey Medical Corporation (JMC)
    • Mustang Bio, Inc.
    • Mustang Therapeutics, Inc. (MBIO)
    • National Holdings Corporation
    • Oncogenuity, Inc.
    • Tamid Bio, Inc.
UsernamePublicRestriction

Register